CLINICAL TRIALS PROFILE FOR MILRINONE LACTATE IN DEXTROSE 5%
✉ Email this page to a colleague
All Clinical Trials for MILRINONE LACTATE IN DEXTROSE 5%
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00446017 ↗ | The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG | Completed | Deutsche Stiftung für Herzforschung | Phase 3 | 2003-06-01 | Myocardial dysfunction necessitating inotropic support is a typical complication after on-pump cardiac surgery. This prospective, randomized pilot-study analyses the metabolic and renal effects of the inotropes adrenaline and milrinone in patients needing inotropic support after coronary-artery-bypass-grafting. With respect to data derived from patients with sepsis shock and results from studies using phosphodiesterase-inhibitors prophylactically, the hypothesis is tested that adrenaline may be associated with unwarranted metabolic effects (hyperlactatemia and hyperglycemia) and renal dysfunction. |
NCT00446017 ↗ | The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG | Completed | University of Luebeck | Phase 3 | 2003-06-01 | Myocardial dysfunction necessitating inotropic support is a typical complication after on-pump cardiac surgery. This prospective, randomized pilot-study analyses the metabolic and renal effects of the inotropes adrenaline and milrinone in patients needing inotropic support after coronary-artery-bypass-grafting. With respect to data derived from patients with sepsis shock and results from studies using phosphodiesterase-inhibitors prophylactically, the hypothesis is tested that adrenaline may be associated with unwarranted metabolic effects (hyperlactatemia and hyperglycemia) and renal dysfunction. |
NCT00695929 ↗ | Levosimendan in Congenital Cardiac Surgery | Completed | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A | 2008-07-01 | Many pediatric patients undergoing cardiac surgery under cardiopulmonary bypass for repair of complex congenital malformations, require inotropic support for low cardiac output syndrome. Milrinone through its positive inotropic and vasodilatory effects is widely used for this purpose. The aim of the study is to compare Milrinone with Levosimendan, a novel inotope with calcium-sensitizing properties. We hypothesized that using Levosimendan would result in reduced serum lactate through a higher cardiac index. |
NCT01088997 ↗ | Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn | Terminated | American Medical Association | N/A | 2010-06-01 | The purpose of this pilot study is to determine a safe dose of milrinone to use in a larger study of babies with persistent pulmonary hypertension of the newborn (PPHN). |
NCT01088997 ↗ | Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn | Terminated | Bedford Pharmaceuticals | N/A | 2010-06-01 | The purpose of this pilot study is to determine a safe dose of milrinone to use in a larger study of babies with persistent pulmonary hypertension of the newborn (PPHN). |
NCT01088997 ↗ | Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn | Terminated | Thrasher Research Fund | N/A | 2010-06-01 | The purpose of this pilot study is to determine a safe dose of milrinone to use in a larger study of babies with persistent pulmonary hypertension of the newborn (PPHN). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MILRINONE LACTATE IN DEXTROSE 5%
Condition Name
Clinical Trial Locations for MILRINONE LACTATE IN DEXTROSE 5%
Trials by Country
Clinical Trial Progress for MILRINONE LACTATE IN DEXTROSE 5%
Clinical Trial Phase
Clinical Trial Sponsors for MILRINONE LACTATE IN DEXTROSE 5%
Sponsor Name